Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference
Coherus BioSciences (Nasdaq: CHRS) will present at the 2024 Jefferies Global Healthcare Conference on June 6, 2024, at 8:30 a.m. EDT/5:30 a.m. PDT.
Senior management will discuss the company's latest developments and strategies.
The presentation can be accessed via a webcast on the Coherus website, and it will be available for replay until July 7, 2024.
- Coherus BioSciences is participating in a high-profile industry conference, which could enhance its visibility and investor interest.
- The availability of the webcast replay until July 7, 2024, allows a broader audience to access the presentation, potentially boosting engagement.
- The announcement does not provide specific details about the content of the presentation, leaving investors uncertain about what new information will be shared.
- There is a lack of financial or clinical data updates in the announcement, offering no immediate insight into the company's performance or progress.
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 8:30 a.m. Eastern Daylight Time / 5:30 a.m. Pacific Daylight Time. The presentation will be accessible via Webcast through a link on the Investor Events and Presentations section of the Coherus website: https://investors.coherus.com/events-presentations. This webcast will be available for replay until July 7, 2024.
Coherus Contact Information:
For Investors:
Jami Taylor
Head of Investor Relations
IR@coherus.com
FAQ
When will Coherus BioSciences present at the 2024 Jefferies Global Healthcare Conference?
How can investors access the Coherus presentation at the Jefferies Global Healthcare Conference?
What is the duration for which the Coherus webcast will be available for replay?